Najat Khan
CEO, President & DirectorDr. Najat Khan, Ph.D is Chief Executive Officer and President of Recursion Pharmaceuticals, Inc. January 1, 2026. She was Chief R&D Officer and Chief Commercial Officer of Recursion Pharmaceuticals, Inc. from July 01, 2024 to January 1, 2026 and serves as its Director since April 15, 2024. Previously, Dr. Khan was the Chief Data Science Officer and Senior Vice President/Global Head, Strategy and Portfolio Organization, R&D, of Johnson and Johnson, which she held from June 2023 to June 2024 and she previously held the following roles with Johnson and Johnson: Chief Data Science Officer and Senior Vice President/Global Head, Strategy and Operations, R&D, from May 2020 to June 2023; Chief Operating Officer, R&D Data Science and Global Head, Strategy and Operations, R&D, from November 2019 to May 2020 and April 2019 to May 2020, respectively; and Head of R&D Strategic Initiatives from March 2018 to March 2019. She was also Co-chair of Johnson and Johnson’s Data Science Council from February 2020 to June 2024. Dr. Khan progressed through several roles of increasing seniority at The Boston Consulting Group, culminating in her positions as Partner within the Healthcare Practice, from August 2011 to February 2018. Dr. Khan has been a member of the Board of Directors of the Alliance for Artificial Intelligence in Healthcare since 2021 and was a Steering Committee member of the White House’s Moonshot CancerX program to enhance outcomes for cancer patients. She is also a founding member and co-chair of Data Science in Industry Roundtable (DISRUPT), a business-focused forum dedicated to driving impact using Data Science, since January 2023. Dr. Khan holds a Ph.D. in Organic Chemistry with a focus in Computational Chemistry from the University of Pennsylvania and a B.S. in Computational Chemistry from Colgate University with a minor in Economics/Business.
Positions
- Company NameRecursion Pharmaceuticals, Inc.Stock CodeRXRXPositionCEO, President & DirectorColleagues
- FHFred HassanChair of the Board
- BRBen R. TaylorCFO & President of Recursion UK
- BMBenjamin MabeyChief Technology Officer
- DHDavid HallettChief Scientific Officer
- NHNathan HatfieldChief Legal Officer & Corporate Secretary
- ZDZavain DarIndependent Director
- RMRobert M. HershbergIndependent Director
- JPJoseph P. MiletichChairman of Therapeutics Advisory Board
